DDR1 as a Biomarker for Ovarian Cancer
Author Information
Author(s): Quan Jinhua, Tetsuro Adachi, Sosuke Yoshihara, Kosuke Tanaka
Primary Institution: Niigata University, Graduate School of Medical and Dental Sciences
Hypothesis
Is DDR1 overexpressed in serous ovarian cancer and associated with clinical outcomes?
Conclusion
DDR1 is overexpressed in serous ovarian cancer and correlates with poor disease-free survival.
Supporting Evidence
- DDR1 was expressed in 63% of serous ovarian cancer tissue samples.
- High-grade tumors showed 79% DDR1 expression compared to 50% in low-grade tumors.
- DDR1 expression correlated with poor disease-free survival.
Takeaway
Researchers found that a protein called DDR1 is found more in ovarian cancer tissues than in normal tissues, which might help doctors understand and treat the cancer better.
Methodology
The study used cDNA subtraction and quantitative real-time PCR to identify and validate DDR1 expression in ovarian cancer tissues.
Potential Biases
Potential selection bias due to the specific patient population and exclusion of borderline tumors.
Limitations
The study had a limited sample size and focused only on serous papillary ovarian cancer.
Participant Demographics
Patients with primary epithelial serous ovarian cancer who underwent surgery.
Statistical Information
P-Value
p = 0.006
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website